TrialBlood2023

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.

Mwanasha H Merrill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.